Edition:
India

XBiotech Inc (XBIT.OQ)

XBIT.OQ on NASDAQ Stock Exchange Global Select Market

4.30USD
16 Aug 2018
Change (% chg)

-- (--)
Prev Close
$4.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,274
52-wk High
$5.80
52-wk Low
$3.70

Latest Key Developments (Source: Significant Developments)

XBiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology
Monday, 16 Apr 2018 

April 16 (Reuters) - XBiotech Inc ::XBIOTECH ANNOUNCES UPCOMING PHASE 2 CLINICAL STUDIES IN DERMATOLOGY.XBIOTECH INC - CO WOULD EVALUATE A NEW SUBCUTANEOUS FORMULATION OF CO'S TRUE HUMAN MONOCLONAL ANTIBODY, MABP1, IN TWO SEPARATE PHASE 2 STUDIES.XBIOTECH INC - UPCOMING PHASE 2 CLINICAL STUDIES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (AD) AND HIDRADENITIS SUPPURATIVA (HS).  Full Article

XBiotech says announces successful completion of EMA GMP inspection
Wednesday, 12 Oct 2016 

XBiotech Inc : XBiotech announces successful completion of EMA GMP inspection . Says findings allow french agency to recommend to EMA xBiotech's current facility for commercial manufacture of xilonix .XBiotech inc - company expects EMA decision on marketing application as early as end of 2016.  Full Article